SurancePlus 2025–2026 Tokenized Reinsurance Update
SurancePlus continues to demonstrate strong performance across its 2025–2026 tokenized reinsurance offerings. The Balanced Yield Token (EtaCat Re), which initially targeted a 20% annual return, is now anticipated to achieve a 25% return, and the High Yield Token (ZetaCat Re) remains on track to achieve its 42% return target. These results reflect our portfolio’s disciplined underwriting approach and highlight how tokenized reinsurance can deliver consistent, uncorrelated returns within the
Platform Expansion and Ecosystem Growth
The Company has advanced the SurancePlus platform through a series of strategic partnerships designed to expand global distribution, infrastructure, and interoperability:
- We have established a strategic presence in the Solana ecosystem through our partnership with Alphaledger, positioning SurancePlus within one of the leading blockchain platforms for real-world asset adoption, with support from ecosystem participants including the
Solana Foundation . - Formed a strategic collaboration with LayerZero, enabling distribution of SurancePlus offerings across more than 160 blockchain networks
In parallel, we have increased our targeted marketing and investor engagement initiatives, contributing to growing awareness and expanding participation.
Catastrophe Risk and 2026–2027 Outlook
The Company is preparing for the 2026–2027 contract cycle and its two tokenized reinsurance offerings, T20 and T42, which are targeting an annual return of 20% and 42%, respectively. Industry commentary, including widely followed reporting by Artemis referencing forecasts from AccuWeather, indicates that the 2026
Strategic Outlook
We believe our current market valuation does not fully reflect the strength of our balance sheet, including our approximately
Management is also evaluating opportunities to expand the SurancePlus model into additional high-quality, cash-generating assets, including the potential tokenization of data centre revenue streams and other opportunities aligned with the growth of artificial intelligence infrastructure. These initiatives are intended to broaden the Company’s tokenization footprint and support long-term shareholder value creation.
Looking Ahead
The Company remains focused on scaling the SurancePlus platform, expanding global distribution, and executing on its growing pipeline of tokenized real-world asset opportunities.
With strong performance across its current offerings, expanding access through strategic partnerships, and continued innovation in product structure, the Company is well positioned to build on its momentum as it enters the 2026–2027 contract cycle.
We have also made meaningful progress expanding our platform, including our entry into the Solana ecosystem and distribution across more than 160 blockchain networks. Looking ahead, we are excited about the upcoming year, including recent reporting from Artemis, indicating El Niño conditions may support a reality of storm numbers being around or even below historical averages.
In parallel, we are evaluating advanced opportunities to extend our model into additional high-quality, cash-generating assets, including the tokenization of data center revenues aligned with the growth of artificial intelligence. We also believe our current market valuation does not fully reflect the strength of our balance sheet, including our cash and restricted position, nor the opportunities we see to drive incremental shareholder value.”
Financial Performance
Net premiums earned for the three months ended
Net premiums earned for the years ended
Net income for the quarter ended
Net loss for the year ended
For the three months ended
For the year ended
As of
Financial Ratios
Loss Ratio. The loss ratio is the ratio of losses and loss adjustment expenses incurred to premiums earned and measures the underwriting profitability of our reinsurance business. The loss ratio increased to 119.9% for the year ended
Acquisition Cost Ratio. The acquisition cost ratio is the ratio of policy acquisition costs and other underwriting expenses to net premiums earned. The acquisition cost ratio measures our operational efficiency in producing, underwriting and administering our reinsurance business. The acquisition cost ratio remained consistent at 11.0% for the year ended
Expense Ratio. The expense ratio is the ratio of policy acquisition costs and general and administrative expenses to net premiums earned. We use the expense ratio to measure our operating performance. For the year ended
Combined ratio. We use the combined ratio to measure our underwriting performance. The combined ratio is the sum of the loss ratio and the expense ratio. For the year ended
Conference Call
Management will host a conference call later today to discuss these financial results, followed by a question and answer session. President and Chief Executive Officer
Date:
Time:
Toll-free number: 877-524-8416
International number: +1 412-902-1028
Please call the conference telephone number 15 minutes before the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact InComm Conferencing at +1-201-493-6280
media@incommconferencing.com
A replay of the call will be available by telephone after
Toll-free replay number: 877-660-6853
International replay number: +1-201-612-7415
Conference ID: 13759252
About
Insurance businesses in the
Our new Web3-focused subsidiary, SurancePlus Inc. (“SurancePlus”), has developed the first “on-chain” reinsurance RWA of its kind to be sponsored by a subsidiary of a publicly traded company. By digitizing interests in reinsurance contracts as on-chain RWAs, SurancePlus has democratized the availability of reinsurance as an alternative investment to both
Forward-Looking Statements
This press release may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project” and other similar words and expressions are intended to signify forward-looking statements. Forward-looking statements are not guarantees of future results and conditions but rather are subject to various risks and uncertainties. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on
Company Contact:
345-749-7570
jmadhu@oxbridgere.com
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Consolidated Balance Sheets
(expressed in thousands of
| At | ||||||||
| 2025 | 2024 | |||||||
| Assets | ||||||||
| Investments: | ||||||||
| Equity securities, at fair value (cost: | - | 113 | ||||||
| Cash and cash equivalents | 268 | 2,135 | ||||||
| Restricted cash and cash equivalents | 6,708 | 3,758 | ||||||
| Premiums receivable | 766 | 1,059 | ||||||
| Other investments | - | 48 | ||||||
| Deferred policy acquisition costs | 102 | 109 | ||||||
| Operating lease right-of-use assets | 43 | 148 | ||||||
| Prepayment and other assets | 150 | 94 | ||||||
| Property and equipment, net | 16 | 1 | ||||||
| Total assets | $ | 8,053 | 7,465 | |||||
| Liabilities and Shareholders’ Equity | ||||||||
| Liabilities: | ||||||||
| Reserve for losses and loss adjustment expenses | 91 | - | ||||||
| Notes payable to noteholders | 118 | 118 | ||||||
| Losses payable | 73 | - | ||||||
| Unearned premiums reserve | 926 | 991 | ||||||
| Operating lease liabilities | 43 | 148 | ||||||
| Accounts payable and other liabilities | 309 | 366 | ||||||
| Total liabilities | 1,560 | 1,623 | ||||||
| Mezzanine Equity | ||||||||
| Due to EpsilonCat Re / DeltaCat Re / EtaCat Re / ZetaCat Re Tokenholders | 518 | 1732 | ||||||
| Shareholders’ equity: | ||||||||
| Ordinary share capital, (par value | 6 | 6 | ||||||
| Additional paid-in capital | 38,047 | 34,105 | ||||||
| Accumulated Deficit | (32,137 | ) | (30,163 | ) | ||||
| Total Oxbridge shareholders’ equity | 5,916 | 3,948 | ||||||
| Non-controlling interests | 59 | 162.00 | ||||||
| Total shareholders’ equity | 5,975 | 4,110 | ||||||
| Total liabilities, mezzanine and shareholders’ equity | 8,053 | 7,465 | ||||||
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Consolidated Statements of Operations
(Unaudited)
(expressed in thousands of
| Three Months Ended | Year Ended | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Revenue | ||||||||||||||||
| Assumed premiums | 53 | - | 2,275 | 2,379 | ||||||||||||
| Change in unearned premiums reserve | 502 | 595 | 12 | (76 | ) | |||||||||||
| Net premiums earned | 555 | 595 | 2,287 | 2,303 | ||||||||||||
| SurancePlus fee income | - | - | 1 | 312 | ||||||||||||
| Net investment and other income | 63 | 60 | 314 | 248 | ||||||||||||
| Realized gain on other investments | 35 | - | ||||||||||||||
| Interest and gain on redemption of Series A-1 preferred shares | - | 47 | - | 47 | ||||||||||||
| Interest and gain on redemption of loan receivable | - | - | - | 41 | ||||||||||||
| Unrealized loss on other investments | - | (208 | ) | (20 | ) | (2,145 | ) | |||||||||
| Change in fair value of equity securities | (42 | ) | (72 | ) | (40 | ) | (260 | ) | ||||||||
| Total revenue | $ | 576 | 422 | $ | 2,577 | 546 | ||||||||||
| Expenses | ||||||||||||||||
| Losses and loss adjustment expenses | 449 | - | 2,742 | - | ||||||||||||
| Policy acquisition costs and underwriting expenses | 61 | 66 | 252 | 254 | ||||||||||||
| General and administrative expenses | 531 | 431 | 3,046 | 1,917 | ||||||||||||
| Total expenses | $ | 1,041 | 497 | $ | 6,040 | 2,171 | ||||||||||
| Loss before loss (income) attributable to tokenholders and non-controlling interests | (465 | ) | (75 | ) | (3,463 | ) | (1,625 | ) | ||||||||
| Loss (income) attributable to tokenholders | 689 | (246 | ) | 1,386 | (962 | ) | ||||||||||
| Income (loss) before income attributable to non-controlling interests | 224 | (321 | ) | (2,077 | ) | (2,587 | ) | |||||||||
| Income attributable to non-controlling interests | (104 | ) | (139 | ) | (2 | ) | (139 | ) | ||||||||
| Net income (loss) attributable to ordinary shareholders | 120 | (460 | ) | (2,079 | ) | (2,726 | ) | |||||||||
| Loss per share attributable to ordinary shareholders | ||||||||||||||||
| Basic and Diluted | 0.02 | (0.05 | ) | (0.28 | ) | (0.45 | ) | |||||||||
| Weighted-average shares outstanding | ||||||||||||||||
| Basic and Diluted | 7,664,122 | 6,121,020 | 7,389,822 | 6,099,051 | ||||||||||||
| Performance ratios to net premiums earned: | ||||||||||||||||
| Loss ratio | 80.9 | % | 0.0 | % | 119.9 | % | 0.0 | % | ||||||||
| Acquisition cost ratio | 11.0 | % | 11.1 | % | 11.0 | % | 11.0 | % | ||||||||
| Expense ratio | 106.7 | % | 83.5 | % | 144.2 | % | 94.3 | % | ||||||||
| Combined ratio | 187.6 | % | 83.5 | % | 264.1 | % | 94.3 | % | ||||||||
Source: